QIAGEN N.V. |
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 39.23 USD | -0.23% |
|
-4.74% | -12.38% |
| 16.04. | Deutsche Bank Research belässt Qiagen auf 'Buy' - Ziel 50 Dollar | DP |
| 10.04. | Bosch setzt auf Wachstum mit Medizintechnik - neuer Sepsis-Test | RE |
Kurzporträt
Mitarbeiterzahl: 5 361
Umsatz nach Geschäftsbereich
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
Consumables and Related
87,8
%
| 1 889 | 88,2 % | 1 726 | 87,8 % | -8.61% |
Instrumentation
12,2
%
| 253 | 11,8 % | 239 | 12,2 % | -5.34% |
Umsatz je Region
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
United States
47,6
%
| 910 | 42,5 % | 935 | 47,6 % | +2.82% |
Europe, Middle East and Africa
30,7
%
| 702 | 32,8 % | 604 | 30,7 % | -13.92% |
Asia Pacific, Japan and Rest of World
16,3
%
| 410 | 19,2 % | 321 | 16,3 % | -21.84% |
Other Americas
4,3
%
| 88 | 4,1 % | 85 | 4,3 % | -3.82% |
Netherlands
1,0
%
| 32 | 1,5 % | 20 | 1,0 % | -35.56% |
Manager
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 01.02.15 |
Metin Colpan
FOU | Founder | 69 | 29.04.96 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 01.01.99 |
Antonio Santos
COO | Chief Operating Officer | - | 01.04.22 |
Philipp von Hugo
CMP | Compliance Officer | 57 | 01.12.03 |
Lezette Young
CMP | Compliance Officer | - | - |
John Gilardi
IRC | Investor Relations Contact | - | 01.10.10 |
Nedal Safwat
PRN | Corporate Officer/Principal | - | - |
Stephany Foster
HRO | Human Resources Officer | - | 01.01.05 |
Jonathan Sheldon
PRN | Corporate Officer/Principal | 52 | 01.01.18 |
Aufsichtsräte
| Aufsichtsräte | Titel | Alter | Seit |
|---|---|---|---|
| Director/Board Member | 74 | 01.06.11 | |
Metin Colpan
FOU | Founder | 69 | 29.04.96 |
Lawrence Rosen
CHM | Chairman | 66 | 26.06.13 |
Elaine Mardis
BRD | Director/Board Member | 62 | 01.01.14 |
| Director/Board Member | 66 | 21.04.23 | |
Toralf Haag
BRD | Director/Board Member | 58 | 08.01.21 |
Ross Levine
BRD | Director/Board Member | 52 | 01.01.16 |
Eva Pisa
BRD | Director/Board Member | 70 | 23.06.22 |
Anteilsklasse
| Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
|---|---|---|---|---|---|
| Aktie A | 1 | 223 904 389 | 220 438 912 ( 98,45 %) | 2 567 594 ( 1,147 %) | 98,45 % |
Unternehmenskontakt
Konzerngesellschaften
| Name | Kategorie und Branche |
|---|---|
QIAGEN GmbH
 QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. |
Miscellaneous Commercial Services
|
QIAGEN Aarhus A/S
 QIAGEN Aarhus A/S Packaged SoftwareTechnology Services QIAGEN Aarhus A/S develops and markets software and hardware solutions and consultancy services within bioinformatics. Its products include workbench, server solutions, database, and modules. The company was founded by Thomas Knudsen and Bjarne Knudsen in 2004 and is headquartered in Aarhus, Denmark. |
Packaged Software
|
QIAGEN Lake Constance GmbH
 QIAGEN Lake Constance GmbH Electronic ComponentsElectronic Technology QIAGEN Lake Constance GmbH develops and produces optical measurement devices for medical, environmental and industrial applications. The company was founded by Thomas Wiest, Klaus Haberstroh, Roland Sackers, Peer Michael Schatz, and Jörg Schickedanz in 1997 and is headquartered in Stockach, Germany. |
Electronic Components
|
Qiagen AB
| |
Qiagen Ltd.
 Qiagen Ltd. Medical/Nursing ServicesHealth Services Qiagen Ltd. engages in other human health activities. The company was incorporated on October 4, 1993 and is headquartered in Manchester, the United Kingdom |
Medical/Nursing Services
|
QIAGEN Instruments AG
 QIAGEN Instruments AG Medical SpecialtiesHealth Technology QIAGEN Instruments AG engages in the development, production, and distribution of analytical instruments and devices. It also acquires participating interests in firms, as well as acquires and utilizes patents, licenses, and other rights. The company was founded on February 28, 1990 and is headquartered in Hombrechtikon, Switzerland. |
Medical Specialties
|
Chemicals: Specialty
| |
QIAGEN Singapore Pte Ltd.
| |
QIAGEN Manchester Ltd.
 QIAGEN Manchester Ltd. Pharmaceuticals: MajorHealth Technology Part of QIAGEN NV, QIAGEN Manchester Ltd. is a pharmaceutical manufacturing company. The private company is based in Manchester, UK. QIAGEN Manchester was founded in 2001. |
Pharmaceuticals: Major
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
| % 1. Jan. | Kap. | |
|---|---|---|
| -12.38% | 8.68 Mrd. | |
| -1.78% | 41.36 Mrd. | |
| +45.26% | 41.3 Mrd. | |
| +4.01% | 39.61 Mrd. | |
| -15.14% | 25.62 Mrd. | |
| +3.16% | 24.09 Mrd. | |
| -24.08% | 18.38 Mrd. | |
| -2.67% | 11.82 Mrd. | |
| +24.76% | 11.85 Mrd. | |
| +7.01% | 11.07 Mrd. |
- Börse
- Aktien
- A400D5 Aktie
- Unternehmen Qiagen N.V.
